Dr. Manju A. Mavanur, MD

Dr. Mavanur practices at Owings Mills Dialysis Center in Halethorpe, Maryland.

Dr. Mavanur's NPI, 1164434932, was assigned on August 12, 2006. Dr. Mavanur holds Maryland license D71314.

Dr. Mavanur's primary practice is Owings Mills Dialysis Center, at 1589 Sulphur Spring Rd, Halethorpe, MD 21227 in Baltimore County. The practice phone is (410) 363-2019.

Dr. Mavanur's primary practice is Owings Mills Dialysis Center in Halethorpe, Maryland. Dr. Mavanur is also affiliated with University of Maryland Medical Center. The medical group on file is Mid-Atlantic Nephrology Associates. Dmand AI also links Dr. Mavanur to 3 more hospitals, 2 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mavanur practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mavanur's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Mavanur's licenses on file in 2 states: Maryland and Connecticut.

CMS data shows 1,525 Medicare services from Dr. Mavanur across 16 procedure codes in 2024, for 476 Medicare patients. Medicare paid $168,308 for them.

CMS counts 476 Medicare patients who saw Dr. Mavanur in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 4.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mavanur's median patient age at 68, with 47% women.

In 2024, Dr. Mavanur wrote 556 Medicare Part D claims for 144 patients. 85% of them were for generic drugs. CMS names the drug for 405 of them, across 14 drugs with 11 or more claims each, at $74,868 in total drug cost. In 2023, CMS named 327 claims across 12 drugs.

Dr. Mavanur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 16 general payments to Dr. Mavanur from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Alexion Pharmaceuticals, Inc. paid the most, $256.